Analysen von Richard Vosser
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 28.10.24 | Bayer Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 25.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 23.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 18.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 18.10.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.10.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.10.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 17.10.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.10.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 14.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.10.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 01.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.09.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 26.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 16.09.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.09.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 02.09.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 16.08.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 09.08.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 05.08.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 01.08.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.08.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 29.07.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 27.07.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 23.07.24 | Bayer Neutral | JP Morgan Chase & Co. | |